Startup that measures blood glucose levels in real-time using a chip-implanted arm patch and an app
Clear.bio has raised €1.7M across 2 funding rounds from 5 investors, most recently a round in Sep 2025. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-09-29 | Other | €1.7M | Business Angels,Horizon Flevoland,Invest International’s Dutch Trade & Investment Fund,The Future Food Fund | View deal → |
| 2022-11-18 | Other | — | Achmea Innovation Fund | View deal → |
